In contrast, cisplatin treatment in head-and-neck carcinoma induces c-Abl, a tyrosine kinase, that phosphorylates ΔNp63α, resulting in its increased binding to YAP, leading to protection from cisplatin-induced apoptosis (Yuan et al., 2010). Here, YAP1 is linked to head and neck carcinoma.